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For patients with an exacerbation of chronic obstructive 
pulmonary disease (COPD), noninvasive positive pressure 
ventilation (NPPV) is considered the standard of care [1] 
and should be available as ﬁ   rst-line therapy in any 
institution that treats acutely ill COPD patients [2]. Most 
randomised control trials of NPPV for acute respiratory 
failure, however, have excluded patients without eﬃ   cient 
clearance of secretions [2]. As a matter of a fact, the 
inability to spontaneously remove respiratory secretions 
has been considered a relative contraindication to applied 
NPPV in acute respiratory failure, especially if the 
inability occurs in patients with impaired consciousness 
and depressed cough [2,3].
Few studies have shown that, within expert units, 
NPPV is feasible and may be applied with success in 
moderate to severe hypercapnic encephalopathy due to 
COPD [4,5]. Diagnostic or therapeutic ﬂ  exible ﬁ  breoptic 
bronchoscopy (FBO) is often necessary in severely ill 
patients, especially in hypoxemic and/or COPD patients. 
Studies have reported that NPPV may be helpful in 
performing a diagnostic FBO with bronchoalveolar 
lavage for suspected pneumonia [6,7]. Limited data exist, 
however, supporting the use of NPPV in COPD patients 
who are not eligible for the technique because of their 
incapability to spontaneously eliminate accumulated 
secretions associated with hypercapnic encephalopathy.
In the previous issue of Critical Care, Scala and 
colleagues provide data that support the use of NPPV with 
early FBO performed by an experienced team in acutely 
decompensated COPD patients with hypercapnic en  cepha-
lopathy and an inability to spontaneously clear copious 
secretions [1]. Th  ey suggested safety and eﬀ  ective  ness of 
this strategy including early therapeutic FBO during NPPV 
performed by an experienced team [1].
Th   e authors performed a 12-month, prospective, 
matched case–control study including 15 decompensated 
COPD patients with copious secretion retention and 
hypercapnic encephalopathy due to community-acquired 
pneumonia who were undergoing NPPV and 15 controls 
intubated and receiving conventional mechanical ventila-
tion [1]. Th   ey showed that the early suction of secretions 
with FBO may increase the chance of NPPV success (12 
out of 15 patients avoided intubation) and that the method 
may be considered a potential alternative option to 
endotracheal intubation Interestingly, this innovative 
strategy includ  ing NPPV was not associated with major 
adverse events, such as complications related to a delayed 
(re)emergent intubation, cardiovascular events and 
pneumothorax. Improvement in arterial blood gases was 
similar in the two groups. Th   is new approach reduces the 
rate of tracheostomy and the nosocomial infections 
associated with endotracheal intubation in comparison 
with a group of COPD patients treated with invasive 
mechanical ventilation. Th   ese data should be interpreted 
with caution, however, as the study was not powered for 
assessing the diﬀ  erences in the rate of tracheostomy and 
nosocomial infections between the groups. Th  e  hospital 
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ventilation were similar in the two groups.
Despite the great interest of these ﬁ   ndings for all 
practicing clinicians, the present study is a case–control 
design using observational data and a lack of randomi-
sation [1], which may bias results in favour of the treat-
ment under investigation. Moreover, the two groups were 
treated in two diﬀ  erent units: the patients in the NPPV 
group were treated in a centre with important expertise 
and experience in the ﬁ  eld of NPPV and FBO techniques, 
and the patients in the control group (intubated and 
controlled ventilation) were treated in another unit with 
less experience – hence limiting the generalisability of 
the conclusions, as indicated by the authors themselves. 
Th  is diﬀ   erence may bias results in favour of the new 
strategy using NPPV with FBO under investigation. Th  e 
ﬁ   ndings may thus not be reproducible in units less 
experienced in NPPV. Criticism may be also directed 
towards the choice of the control group including 
patients treated initially with invasive ventilation who 
had not previously received NPPV. One could argue that 
a comparison between NPPV plus FBO and NPPV alone 
may have been a more appropriate design to address the 
clinical outcomes of the study.
Larger randomised controlled studies are necessary to 
conﬁ  rm these preliminary encouraging results. Especially, 
at least one trial, performed in a single centre, comparing 
NPPV combined or not with FBO in less severe COPD 
decompensated patients with impaired mucous clearance 
could be of help to integrate with the ﬁ  ndings of the 
present study.
As NPPV is a harmful therapeutic in hypoxemic 
patients, especially in COPD patients, even when it is 
used in the best and optimal conditions by a skilled team 
[2,3], it can be unsafe if used in nonoptimal conditions. It 
is mandatory that the more severe patients treated by 
NPPV (with or without FBO) should be closely moni-
tored in an intensive care unit setting and, if there is no 
improvement in gas exchange or vital signs within the 
ﬁ  rst 1 to 2 hours, intubation should be planned with no 
delay in the best conditions [8].
In conclusion, extending the indication of NPPV use is 
always challenging and exciting. It is unfortunate that the 
preliminary successes of the Scala and colleagues study 
[1] have yet to be followed up, but future studies should 
consider the potential risk–beneﬁ  t ratio of such a strategy 
(NPPV combined with FBO in COPD with hypercapnic 
encephalopathy) in the most challenging patients.
Abbreviations
COPD, chronic obstructive pulmonary disease; FBO, fi  breoptic bronchoscopy; 
NPPV, noninvasive positive pressure ventilation.
Competing interests
The authors declare that they have no competing interests.
Published: 9 June 2010
References
1.  Scala R, Naldi M, Maccari U: Early fi  beroptic bronchoscopy during non-
invasive ventilation in patients with decompensated chronic obstructive 
pulmonary disease due to community-acquired-pneumonia. Crit Care 
2010, 14:R80.
2.  Robert D, Argaud L: Clinical review: long-term noninvasive ventilation. Crit 
Care 2007, 11:210.
3. Evans  TW:  International Consensus Conferences in Intensive Care 
Medicine: non-invasive positive pressure ventilation in acute respiratory 
failure. Organised jointly by the American Thoracic Society, the European 
Respiratory Society, the European Society of Intensive Care Medicine, and 
the Societe de Reanimation de Langue Francaise, and approved by the 
ATS Board of Directors, December 2000. Intensive Care Med 2001, 
27:166-178.
4.  Diaz GG, Alcaraz AC, Talavera JC, Perez PJ, Rodriguez AE, Cordoba FG, Hill NS: 
Noninvasive positive-pressure ventilation to treat hypercapnic coma 
secondary to respiratory failure. Chest 2005, 127:952-960.
5.  Scala R, Naldi M, Archinucci I, Coniglio G, Nava S: Noninvasive positive 
pressure ventilation in patients with acute exacerbations of COPD and 
varying levels of consciousness. Chest 2005, 128:1657-1666.
6.  Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, Meduri GU: 
Noninvasive positive-pressure ventilation vs. conventional oxygen 
supplementation in hypoxemic patients undergoing diagnostic 
bronchoscopy. Chest 2002, 121:1149-1154.
7.  Maitre B, Jaber S, Maggiore SM, Bergot E, Richard JC, Bakthiari H, Housset B, 
Boussignac G, Brochard L: Continuous positive airway pressure during 
fi  beroptic bronchoscopy in hypoxemic patients. A randomized 
double-blind study using a new device. Am J Respir Crit Care Med 2000, 
162(3 Pt 1):1063-1067.
8.  Jaber S, Jung B, Corne P, Sebbane M, Muller L, Chanques G, Verzilli D, Jonquet 
O, Eledjam JJ, Lefrant JY: An intervention to decrease complications related 
to endotracheal intubation in the intensive care unit: a prospective, 
multiple-center study. Intensive Care Med 2009, 36:248-255.
doi:10.1186/cc9023
Cite this article as: Jaber S, Chanques G: Another step for noninvasive 
ventilation in chronic obstructive pulmonary disease patients! Critical Care 
2010, 14:163.
Jaber and Chanques Critical Care 2010, 14:163 
http://ccforum.com/content/14/3/163
Page 2 of 2